))
In this limited podcast series, we’ve brought together a series of conversations with experts from medical science to finance to help demystify investing in biotech, medtech and digital health (also known as the life sciences). This podcast has been brought to you by Life Sciences WA (Western Australia’s Life Sciences Industry Association) in collaboration with Talking HealthTech. It has been possible with funding support from the West Australian government through the New Industries Fund an ...
…
continue reading
1
Emerging opportunities in medicinal cannabis and psychedelics. Michael Winlo - Emyria Ltd & Fleta Solomon - Little Green Pharma
58:11
58:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
58:11
In this episode of the LSWA podcast, host Tracey Wilkinson interviews Fleta Solomon and Michael Winlo, two experts in the field of psychedelic-assisted therapy and medical cannabis. They discuss the potential of these treatments to revolutionise mental health care and provide a more holistic approach to patient care. The conversation begins with a …
…
continue reading
1
Pathway to market: the role of Clinical Trials. Natalie Barber - Chrysalis Advisory & Peter Richmond - CAHS
31:17
31:17
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
31:17
In this episode of the LSWA podcast, host Tracey Wilkinson sits down with Natalie Barber, the director of Clinical Operations at Chrysalis Advisory, and Professor Peter Richmond from the University of Western Australia. Natalie and Peter discuss their respective roles in the clinical trial space. Peter, a paediatrician, focuses on improving childre…
…
continue reading
1
Taking a lifesciences company global: what to expect from an investor perspective. Paul Anderson - Orthocell
35:24
35:24
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
35:24
In this episode of the Investor Meets Innovator Podcast, host Peter Birch sits down with Paul Anderson, the Managing Director of Orthocell. With over 25 years of experience in the medical space and a background in device development and regenerative medicine, Paul shares his insights on the life sciences industry and the journey of bringing innovat…
…
continue reading
1
Engaging with Academics and Tech Transfer Offices. Simon Handford - University TTO & Angela Fonceca - Academic
45:27
45:27
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
45:27
In this episode of LSWA Investor Meets Innovator, Host Tracey Wilkinson talks with Simon Handford and Angela Fonceca about the challenges and complexities of tech transfer offices and taking research to commercialisation. They discuss the challenges of taking an innovation from academia and industry, the slow pace of negotiations, issues with fundi…
…
continue reading
1
Engaging with founding inventors: the investor and inventor perspective. Ian Brown & Intan Oldakowska - Rex Ortho
27:06
27:06
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
27:06
In this episode of the Investor Meets Innovator Podcast, host Peter Birch is joined by Ian Brown, Executive Chairman, and Intan Oldakowska, Chief Scientific Officer, of Rex Ortho. They discuss the journey of Rex Ortho, a platform technology company focused on orthopaedic fixations, particularly in proximal femoral fractures. Intan shares the backgr…
…
continue reading
1
Investing with Impact in the Life Sciences - Tenmile, Arjun Balaji
25:34
25:34
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
25:34
In this episode of the Investor Meets Innovator Podcast, host Peter Birch speaks with Arjun Balaji, an analyst with a clinical background at Tenmile, a venture capital firm in Perth, Western Australia. Arjun shares his background in medicine and his journey into the world of biotech startups before transitioning to investing. In this episode Arjun …
…
continue reading
1
Investing with Impact in the Life Sciences Dr Melissa McBurnie - Brandon Capital
29:14
29:14
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
29:14
In this episode of the Investor Meets Innovator Podcast, host Peter Birch sits down with Dr Melissa McBurnie, Partner and Head of Impact at Brandon Capital. You will hear about how Brandon Capital approaches investing with impact in the life sciences and get some insights into the processes that they use when making an investment in this space. You…
…
continue reading
In this episode of the Life Sciences WA Podcast, Dr Tara Speranza discusses her work as a healthcare and biotech analyst at Bell Potter Securities. Dr Speranza is part of a group of three analysts who cover the healthcare and biotech sector in Australia, focusing on companies listed on the ASX. She has a background in molecular biology and endocrin…
…
continue reading
Investment in life sciences in Western Australia is an area of great interest, as shown by the recent Life Sciences WA podcast episode featuring guests Greg Riebe and Steve Elias. Riebe is a company director and angel investor with decades of experience in commercialising emerging technologies and is currently a Commercialisation Facilitator for th…
…
continue reading
1
Medical Devices 101 and Local Insights about the WA Life Sciences Sector
40:36
40:36
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
40:36
This episode features conversations with Paul Watt, Co-Founder and Executive Chair of Avicena Systems and Liddy McCall, Director of Yuuwa Ventures Investment in life sciences in Western Australia has grown significantly in recent years. This growth has been driven by several factors, including the state's strong research and development infrastruct…
…
continue reading
In this episode of the Life Sciences WA Podcast, Dr Bi Mian discusses his work with the Australian Medical Angels, a medical syndicate that focuses on investing in HealthTech start-ups in Australia. Dr Mian, who is a medical doctor and runs a multi-specialist medical centre in regional New South Wales, founded the group with his co-founder Dr Amand…
…
continue reading
In this podcast episode of the Life Sciences WA Podcast, the guest was Bronwyn LeGrice, CEO of ANDHealth. The focus of the discussion was on investing and commercialising digital health. LeGrice introduced herself and discussed her background, which included seven years in venture capital and over 20 years in the commercialisation of medical techno…
…
continue reading
Dr Alma Fulurija Dr Alma Fulurija is the Head of the Strep A Vaccines team at Telephone Kids Institute. In this interview, she discussed the process of vaccine development, which is a long, expensive, and high-risk process, but has the potential for high rewards if successful. The Covid-19 pandemic has shown that vaccine development can be done fas…
…
continue reading
Glenn Butcher is the CEO of FundWA, a venture capital firm focused on investing in technology-enabled innovation businesses in Western Australia. In this interview, he discussed the potential for growth and success in this area, highlighting the state's strong track record in life sciences research and the potential for commercialising this researc…
…
continue reading
